# Ergometrine

## Ergometrine 0.2mg

##### 

| TAH Drug Code      | OERGO                                                                                                                                                                                                                                                                                                            |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Postpartum haemorrhage caused by uterine atony.                                                                                                                                                                                                                                                                  |
| Dosing             | Adult 1 tablet TID. the maximum dose: 2 mg/day. [Micromedex 2021/08/04] Postpartum hemorrhage; Treatment and Prophylaxis: Minimization of late postpartum hemorrhage, 0.2 to 0.4 mg (1 or 2 tablets ) orally or sublingually every 6 to 12 hours until the danger of uterine atony has passed, usually 48 hours. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                    |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                    |
| Contraindications  | Threatened spontaneous abortion, vascular diseases, impaired renal or hepatic function, pregnancy, induction of labor.                                                                                                                                                                                           |
| Adverse Effects    | Nausea, vomiting, headache, dizziness, abdominal pain, hypertension, bradycardia, dyspnea, ergotism.                                                                                                                                                                                                             |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                          |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                          |

